Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of α4β2 and α3β2 Nicotinic Acetylcholine Receptors
Abstract
alpha4beta2 nicotinic acetylcholine receptors (nAChRs) are recognized as the principal nicotine binding site in brain. Recombinant alpha4beta2 nAChR demonstrate biphasic concentration-response relationships with low- and high-EC50 components. This study shows that untranslated regions (UTR) can influence expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nAChR. Oocytes injected with alpha4 and beta2 RNA lacking UTR expressed biphasic concentration-response relationships for acetylcholine with high-sensitivity EC50 values of 0.5 to 2.5 microM (14-24% of the population) and low-sensitivity EC50 values of 110 to 180 microM (76-86%). In contrast, message with UTR expressed exclusively the high-sensitivity alpha4beta2 nAChR subform with an acetylcholine EC50 value of 2.2 microM. Additional studies revealed pharmacological differences between high- and low-sensitivity alpha4beta2 subforms. Whereas the antagonists dihydro-beta-erythroidine (IC50 of 3-6 nM) and methyllycaconitine (IC50 of 40-135 nM) were not selective between high- and low-sensitivity alpha4beta2, chlorisondamine, mecamylamine, and d-tubocurarine were, respectively, 100-, 8-, and 5-fold selective for the alpha4beta2 subform with low sensitivity to acetylcholine. Conversely, agonists that selectively activated the high-sensitivity alpha4beta2 subform with respect to efficacy as well as potency were identified. Furthermore, two of these agonists were shown to activate mouse brain alpha4beta2 as well as the ferret high-sensitivity alpha4beta2 expressed in Xenopus laevis oocytes. With the use of UTR-containing RNA, exclusive expression of a novel high-sensitivity alpha3beta2 nAChR was also achieved. These studies 1) provide further evidence for the existence of multiple subforms of alpha4beta2 nAChR, 2) extend that to alpha3beta2 nAChR, 3) demonstrate UTR influence on beta2-containing nAChR properties, and 4) reveal compounds that interact with alpha4beta2 in a subform-selective manner.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neither hexamethonium nor chlorisondamine are foot-in-the-door blockers at high-sensitivity α4β2 receptors.
“In fact, neither hexamethonium (61) nor chlorisondamine (62), two well-studied channel blockers at nAChRs, are foot-in-the door blockers at high-sensitivity α4β2 receptors;”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [62]
Cites
Clarke, P. B. S., Schwartz, R., Paul, S. M., Cb, P., & Pert, A. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01307.1985 · Cited by 1,037 · see citing works
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970 · see citing works
Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08832-7 · Cited by 880 · see citing works
Upstream Open Reading Frames as Regulators of mRNA Translation
Morris, D. R., & Geballe, A. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8635-8642.2000 · Cited by 736 · see citing works
Alkondon, M., & Albuquerque, E. X. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38283-2 · Cited by 554 · see citing works
Champtiaux, N., Gotti, C., Cordero‐Erausquin, M., David, D. J. P., Przybylski, C., Léna, C., Clementi, F., Moretti, M., Rossi, F., Novère, N. G. L., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07820.2003 · Cited by 509 · see citing works
Translational control by the 3′-UTR: the ends specify the means
Mazumder, B., Seshadri, V., & Fox, P. L. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00002-1 · Cited by 506 · see citing works
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.332 · Cited by 422 · see citing works
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36376-1 · Cited by 405 · see citing works
Chavez-Noriega, L. E., Crona, J. H., Washburn, M. S., Urrutia, A., Elliott, K. J., & Johnson, E. C. (1997) · PubMed · Cited by 392 · see citing works
Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function
Buisson, B., & Bertrand, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01819.2001 · Cited by 361 · see citing works
Zoli, M., Novère, N. G. L., Hill, J. A., & Changeux, J. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01912.1995 · Cited by 338 · see citing works
Gerzanich, V., Peng, X.-D., Wang, F., Wells, G. B., Anand, R., Fletcher, S. R., & Lindstrom, J. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10533-6 · Cited by 290 · see citing works
Bringing the role of mRNA decay in the control of gene expression into focus
Wilusz, C. J., & Wilusz, J. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.07.011 · Cited by 268 · see citing works
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works
Kuryatov, A., Gerzanich, V., Nelson, M. E., Olale, F., & Lindstrom, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09035.1997 · Cited by 227 · see citing works
Zwart, R., & Vijverberg, H. P. M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1124 · Cited by 215 · see citing works
Whiting, P. J., Schoepfer, R., Lindström, J., & Priestley, T. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15355-8 · Cited by 200 · see citing works
Alkondon, M., & Albuquerque, E. X. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45007-3 · Cited by 197 · see citing works
Human α4β2 Neuronal Nicotinic Acetylcholine Receptor in HEK 293 Cells: A Patch-Clamp Study
Buisson, B., Gopalakrishnan, M., Arnerić, S. P., Sullivan, J. P., & Bertrand, D. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07880.1996 · Cited by 183 · see citing works
Gopalakrishnan, M., Monteggia, L. M., Anderson, D. J., Molinari, E. J., Piattoni-Kaplan, M., Donnelly-Roberts, D., Arneric, S. P., & Sullivan, J. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12264-7 · Cited by 178 · see citing works
Labarca, C., Schwarz, J., Deshpande, P., Schwarz, S., Nowak, M. W., Fonck, C., Nashmi, R., Kofuji, P., Dang, H., Shi, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041582598 · Cited by 177 · see citing works
Human α4β2 Acetylcholine Receptors Formed from Linked Subunits
Zhou, Y., Nelson, M. E., Kuryatov, A., Choi, C., Cooper, J., & Lindstrom, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09004.2003 · Cited by 174 · see citing works
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37064-8 · Cited by 174 · see citing works
Olale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. M. (1997) · PubMed · Cited by 172 · see citing works
Bertrand, D., Ballivet, M., & Rungger, D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1993 · Cited by 158 · see citing works
Paradiso, K. G., Zhang, J., & Steinbach, J. H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06561.2001 · Cited by 144 · see citing works
Neuronal nicotinic acetylcholine receptor β‐subunit is coded for by the cDNA clone α4
Whiting, P. J., Esch, F. S., Shimasaki, S., & Lindstrom, J. M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80272-7 · Cited by 134 · see citing works
Marks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J., & Collins, A. C. (1999) · PubMed · Cited by 126 · see citing works
Self-citationMarks, M. J., Farnham, D. A., Grady, S. R., & Collins, A. C. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10175-4 · Cited by 112 · see citing works
Self-citationPotentiation of Human α4β2 Neuronal Nicotinic Acetylcholine Receptor by Estradiol
Curtis, L., Buisson, B., Bertrand, S., & Bertrand, D. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.127 · Cited by 94 · see citing works
Champtiaux, N., & Changeux, J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007023339247 · Cited by 88 · see citing works
Human α 7 nicotinic acetylcholine receptor responses to novel ligands
Briggs, C. A., McKenna, D. G., & Piattina-kaplan, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00028-5 · Cited by 88 · see citing works
Self-citationAlkondon, M., & Albuquerque, E. X. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10528-4 · Cited by 88 · see citing works
Marks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 81 · see citing works
Self-citationMarks, M. J., Whiteaker, P., Calcaterra, J., Stitzel, J. A., Bullock, A. E., Grady, S. R., Picciotto, M. R., Changeux, J.-P., & Collins, A. C. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38240-0 · Cited by 79 · see citing works
Self-citationChavez-Noriega, L. E., Gillespie, A. J., Stauderman, K. A., Crona, J. H., Claeps, B. O., Elliott, K. J., Reid, R. T., Rao, T. S., Veliçelebi, G., Harpold, M. M., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00134-9 · Cited by 73 · see citing works
Ligand Binding and Activation of Rat Nicotinic α4β2 Receptors Stably Expressed in HEK293 Cells
Sabey, K., Paradiso, K. G., Zhang, J., & Steinbach, J. H. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.58 · Cited by 66 · see citing works
Houlihan, L. M., Slater, Y., Guerra, D. L., Peng, J., Kuo, Y., Lukas, R. J., Cassels, B. K., & Bermúdez, I. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00481.x · Cited by 64 · see citing works
Papke, R. L., Webster, J. C., Lippiello, P. M., Bencherif, M., & Francis, M. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750204.x · Cited by 63 · see citing works
Marszalec, W., Aistrup, G. L., & Narahashi, T. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199903000-00009 · Cited by 63 · see citing works
Champtiaux, N., & Changeux, J. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45016-4 · Cited by 53 · see citing works
α3, β2, and β4 Form Heterotrimeric Neuronal Nicotinic Acetylcholine Receptors in Xenopus Oocytes
Colquhoun, L. M., & Patrick, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062355.x · Cited by 49 · see citing works
Covernton, P. J. O., & Connolly, J. G. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00185-5 · Cited by 47 · see citing works
Papke, R. L., Craig, A. G., & Heinemann, S. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39002-6 · Cited by 47 · see citing works
Modulation by estrogens and xenoestrogens of recombinant human neuronal nicotinic receptors
Nakazawa, K., & Ohno, Y. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01389-9 · Cited by 34 · see citing works
COURT, J. A., Perry, E. K., Spurden, D., Lloyd, S. R., Gillespie, J., Whiting, P. J., & Barlow, R. B. (1994) · Brain Research · doi:10.1016/0006-8993(94)91721-3 · Cited by 31 · see citing works
High Throughput Electrophysiology Using a Fully Automated, Multiplexed Recording System
Trumbull, J. D., Maslana, E. S., McKenna, D. G., Nemcek, T. A., Niforatos, W., Pan, J., Parihar, A. S., Shieh, C., Wilkins, J. A., Briggs, C. A., et al. (2003) · Receptors and Channels · doi:10.1080/10606820308252 · Cited by 31 · see citing works
Self-citationKuo, Y., Xu, L., Eaton, J. B., Zhao, L., Wu, J., & Lukas, R. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084954 · Cited by 29 · see citing works
The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity α4β2 nAChRs
Kim, H., Flanagin, B. A., Qin, C., Macdonald, R. L., & Stitzel, J. A. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00167-9 · Cited by 27 · see citing works
Lin, N., Li, Y., He, Y., Holladay, M. W., Kuntzweiler, T. A., Anderson, D. J., Campbell, J. E., & Arnerić, S. P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00030-0 · Cited by 23 · see citing works
Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds
Hogg, R. C., & Bertrand, D. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.075 · Cited by 14 · see citing works
High Throughput Electrophysiology Using a Fully Automated, Multiplexed Recording System
Trumbull, J. D., Maslana, E. S., McKenna, D. G., et al. (2003) · Receptors and Channels · doi:10.3109/10606820308252 · Cited by 7 · see citing works
Flagged first, then by citations
2 of the 55 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286 · see citing works
Tapia, L., Kuryatov, A., & Lindstrom, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030445 · Cited by 196 · see citing works
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · see citing works
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163 · see citing works
Zwart, R., Carbone, A. L., Moroni, M., Bermudez, I., Mogg, A. J., Folly, E. A., Broad, L. M., Williams, A. C., Zhang, D., Ding, C., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045104 · Cited by 111 · see citing works
Timmermann, D. B., Sandager‐Nielsen, K., Dyhring, T., Smith, M., Jacobsen, A., Nielsen, E., Grunnet, M., Christensen, J., Peters, D., Kohlhaas, K. L., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01989.x · Cited by 103 · see citing works
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100 · see citing works
Allosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Faghih, R., Gopalakrishnan, M., & Briggs, C. A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070256g · Cited by 86 · see citing works
Self-citationMoroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81 · see citing works
Greenbaum, L., & Lerer, B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.59 · Cited by 73 · see citing works
Gotti, C., Moretti, M., Meinerz, N. M., Clementi, F., Gaimarri, A., Collins, A. C., & Marks, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045203 · Cited by 68 · see citing works
Self-citationα6* Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience Circuit
Mackey, E. D. W., Engle, S. E., Kim, M. R., O’Neill, H. C., Wageman, C. R., Patzlaff, N. E., Wang, Y., Grady, S. R., McIntosh, J. M., Marks, M. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0007-12.2012 · Cited by 63 · see citing works
Self-citationRole of channel activation in cognitive enhancement mediated by α7 nicotinic acetylcholine receptors
Briggs, C. A., Grønlien, J. H., Curzon, P., Timmermann, D. B., Ween, H., Thorin‐Hagene, K., Kerr, P., Anderson, D. J., Malysz, J., Dyhring, T., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00426.x · Cited by 62 · see citing works
Self-citationSon, C. D., Moss, F. J., Cohen, B. N., & Lester, H. A. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.054494 · Cited by 58 · see citing works
Nicotinic receptor-based therapeutics and candidates for smoking cessation
Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.002 · Cited by 56 · see citing works
Gold, A. B., Keller, A. B., & Perry, D. C. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.076 · Cited by 55 · see citing works
Hauser, T. A., Hepler, C. D., Kombo, D. C., Grinevich, V. P., Kiser, M. N., Hooker, D. N., Zhang, J., Mountfort, D. O., Selwood, A. I., Akireddy, S. R., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.009 · Cited by 50 · see citing works
Anderson, D. J., Malysz, J., Grønlien, J. H., El Kouhen, R., Håkerud, M., Wetterstrand, C., Briggs, C. A., & Gopalakrishnan, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.024 · Cited by 44 · see citing works
Self-citationCell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation
Nashmi, R., & Lester, H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.040 · Cited by 43 · see citing works
Millar, N. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.015 · Cited by 36 · see citing works
Characterization of a Nicotine-Sensitive Neuronal Population in Rat Entorhinal Cortex
Tu, B., Gu, Z., Shen, J., Lamb, P. W., & Yakel, J. L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2580-09.2009 · Cited by 34 · see citing works
Fedorov, N. B., Benson, L. C., Graef, J. D., Lippiello, P. M., & Bencherif, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146910 · Cited by 34 · see citing works
Capelli, A. M., Castelletti, L., Chen, Y. H., Keyl, H. V. D., Pucci, L., Oliosi, B., Salvagno, C., Bertani, B., Gotti, C., Powell, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01213.x · Cited by 34 · see citing works
Transcriptional regulation by nicotine in dopaminergic neurons
Henley, B. M., Williams, B. A., Srinivasan, R., Cohen, B. N., Xiao, C., Mackey, E. D. W., Wold, B. J., & Lester, H. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.031 · Cited by 33 · see citing works
Paterson, N. E., Min, W., Hackett, A., Lowe, D., Hanania, T., Caldarone, B. J., & Ghavami, A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.037 · Cited by 30 · see citing works
Selectivity of ABT-089 for α4β2* and α6β2* nicotinic acetylcholine receptors in brain
Marks, M. J., Wageman, C. R., Grady, S. R., Gopalakrishnan, M., & Briggs, C. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.022 · Cited by 30 · see citing works
Self-citationWeltzin, M. M., & Schulte, M. K. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223933 · Cited by 28 · see citing works
High affinity and low affinity heteromeric nicotinic acetylcholine receptors at central synapses
d’Incamps, B. L., & Ascher, P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.273128 · Cited by 18 · see citing works
α3 and α7 nAChR-mediated Ca2+ transient generation in IMR-32 neuroblastoma cells
Ween, H., Thorin‐Hagene, K., Andersen, E., Grønlien, J. H., Lee, C., Gopalakrishnan, M., & Malysz, J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.005 · Cited by 15 · see citing works
Genetic matters: Thirty years of progress using mouse models in nicotinic research
Marks, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.05.021 · Cited by 13 · see citing works
Self-citationScanio, M. J. C., Shi, L., Bunnelle, W. H., Anderson, D. J., Helfrich, R. J., Malysz, J., Thorin‐Hagene, K., Handel, C. E. V., Marsh, K. C., Lee, C., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201045m · Cited by 6 · see citing works
Reithmair, M., Aichinger, E., Pfaffl, M. W., Steinlein, O. K., & Pfob, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066157 · Cited by 4 · see citing works
Daniello-Weltzen, M. M. (2011) · ScholarWorks - UA (University of Alaska System)
BindingDB Entry 50038292: Allosteric modulators of the alpha7 nicotinic acetylcholine receptor.
BindingDB (2012) · UC San Diego · doi:10.7270/q2ws8v3b
- Authors
- Briggs, C. A., Gubbins, E. J., Marks, M. J., Putman, C. B., Thimmapaya, R., Meyer, M. D., & Surowy, C. S.
- Affiliations
- Abbott (United States) (US)
- ORCID
- Marks, Michael J.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 70
- Issue
- 1
- Pages
- 227-240
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2284817657
- Cited by
- 33
- References
- 55
- Citations by year
- 2015: 1 · 2014: 1 · 2013: 3 · 2012: 3
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nicotinic acetylcholine receptors, alpha4beta2 nAChR, alpha3beta2 nAChR, untranslated regions, dihydro-beta-erythroidine, methyllycaconitine, mecamylamine, chlorisondamine, tubocurarine, nicotinic agonists, nicotinic antagonists
- MeSH terms
- Acetylcholine, Aconitine, Animals, Chlorisondamine, Dihydro-beta-Erythroidine, Dose-Response Relationship, Drug, Estradiol, Female, Ferrets, Membrane Potentials, Mice, Inbred C57BL, Nicotine, Oocytes, Receptors, Nicotinic, Tubocurarine, Xenopus laevis, Gene Expression, Nicotinic Agonists, Nicotinic Antagonists, Protein Isoforms, 5' Untranslated Regions, Protein Subunits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review